WebAug 23, 2024 · Dr Andreas Eberhorn has many years of experience in the areas of marketing and sales and will be responsible for marketing and sales in his role on the … WebAug 23, 2024 · Dr Jürgen Ott will leave the company by mutual agreement on 31 August 2024. As of 1 September 2024, Dr Andreas Eberhorn (47) will take office as Chief Marketing Officer at Dermapharm. Dr Andreas Eberhorn has many years of experience in the areas of marketing and sales and will be responsible for marketing and sales in his …
Dr. Andreas Eberhorn on LinkedIn: Head Commercial Excellence …
WebPříspěvek uživatele Dr. Andreas Eberhorn Dr. Andreas Eberhorn CMO, Vorstand Marketing & Vertrieb 4 měs. WebMay 10, 2024 · Dr. Andreas Eberhorn Head Specialty, Management board member of Hexal AG at HEXAL AG. Phone. Email. Corina Wallensteiner HR Manager at HEXAL AG. Phone. Email. Gordon Ueck Strategic Sourcing Manager at Hexal AG. Phone. Email. Marion Deuter Manager Medical and Regulatory Affairs at HEXAL AG. Phone. Email. Ina Otto disciplinary statement template
mibe Pharma UK Ltd. - Dermapharm
WebArkopharma ofrece productos 100% naturales gracias al desarrollo de la "Galénica verde", técnica patentada en 2024. Tras probar cientos de materias primas de… WebAndreas. Please go ahead. Dr Andreas Eberhorn Thanks a lot, Britta, and welcome from my side. I will give you a deeper look into three parts today. First, shed light on the drivers of our ongoing growth of the branded pharmaceuticals. Then second, how we move on with our cannabis business, to strengthen the segment of herbal extracts. WebKarin Samusch Dr. Andreas Eberhorn ppa.: Beate Engelbrecht Martina Kuhn Kathrin Mogel (Gesamtprokura gemeinsam mit einem Geschäftsführer oder einem anderen Prokuristen) Contact: Telephone: +49 (0)89 / 641 86-0 Telefax: +49 (0)89 / 641 86-130 E-Mail: [email protected]. Register entry: disciplinary steps acas